It is a trading private limited company based in Delhi, Delhi, India, established in 2012.
2012 | Delhi, Delhi, India | ActiveCellcyte Mediserve Private Limited, a active private limited company, was established on 01 March 2012 in Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U24100DL2012PTC232261. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Munindra Kumar (Director), Himanshu Kumar Gupta (Director). Past directors included Reyaz Ahmad Reyaz, Ruchika Gupta, Anupam Lata. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 45 A, Amar Plaza, Office No. 305, Second Floor, Hasanpur Main Road, I.P. Extension, Delh, I-110092, Delhi, Delhi, 110092.
U24100DL2012PTC232261
232261
01 March 2012
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Cellcyte Mediserve Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Munindra Kumar | Director | 28 Jul 2023 | Current |
| Himanshu Kumar Gupta | Director | 28 Jul 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Dec 2012 | Past |
| Pramod Abcsdd | Director | 02 Aug 2023 | Past |
| Pramod Abcsdd | Director | 02 Aug 2023 | Past |
| Pramod Abcsdd | Director | 02 Mar 2020 | Past |
| Pramod Abcsdd | Director | 02 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cellcyte Mediserve Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Cellcyte Mediserve had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cellcyte Mediserve, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cellcyte Mediserve, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellcyte Mediserve's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Cellcyte Mediserve Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Cellcyte Mediserve Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Munindra Kumar was appointed as a Director was appointed as a Director on 28 Jul 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
The activity Himanshu Kumar Gupta was appointed as a Director was appointed as a Director on 28 Jul 2023 & has been associated with this company since 2 years 4 months . was completed.
Progress on Cellcyte Mediserve Private Limited was registered on 01 Mar 2012 with Roc Delhi & aged 13 years 9 months as per MCA records. was documented.
The CIN of Cellcyte Mediserve Private Limited is U24100DL2012PTC232261.
Cellcyte Mediserve Private Limited is headquartered at 45 A, Amar Plaza, Office No. 305, Second Floor, Hasanpur Main Road, I.P. Extension, Delh, I-110092, Delhi, Delhi, 110092.
Cellcyte Mediserve Private Limited was incorporated on 01 March 2012.
The current directors of Cellcyte Mediserve Private Limited are
The primary industry of Cellcyte Mediserve Private Limited is Trade.
Cellcyte Mediserve Private Limited is unlisted.
The authorized capital of Cellcyte Mediserve Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Cellcyte Mediserve Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX